CD8A and breast carcinoma: To address this urgent need, this study leverages multiplexed profiling of both CD8+ T cells and VEGFR2+ expressing tumor cells in 4T1 murine breast cancer tumors with surface-enhanced Raman spectroscopy (SERS) using multiplexed gold nanostars (MGNs).